VesiCURE Therapeutics
PrivateLast Round
Angel
Sep 17, 2021
Momentum
Top 50%
of companies Caplight tracks
Company Overview
VesiCURE Therapeutics is a biotechnology company that researches and develops exosome innovative drugs and drug delivery platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VesiCURE Therapeutics Comparables
Compare VesiCURE Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TheraXyte BioScience | 87% | |
| Carmine Therapeutics | 83% | |
| Shanghai Stexo Biotechnology Co., Ltd. | 79% |
VesiCURE Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Sep 17, 2021 |
VesiCURE Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Angel |
| Legend Star | Angel |
| YuanBio Venture Capital | Angel |
| Northern Light Venture Capital | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors grew 394% MoM, reaching 1.8K.
- Jan 22, 2026
Monthly visitors increased 34% MoM.
VesiCURE Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VesiCURE Therapeutics's valuation, stock price, and market status.
Is VesiCURE Therapeutics a public or private company?
VesiCURE Therapeutics is a private company.
What is the current stock price of VesiCURE Therapeutics?
VesiCURE Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is VesiCURE Therapeutics worth (valuation)?
Valuation information for VesiCURE Therapeutics is not publicly available.
Can I buy VesiCURE Therapeutics stock?
VesiCURE Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was VesiCURE Therapeutics's last funding round?
VesiCURE Therapeutics's most recent funding round was Angel on September 17, 2021.
Who are the main investors in VesiCURE Therapeutics?
Key investors in VesiCURE Therapeutics include YuanBio Venture Capital.
Will VesiCURE Therapeutics IPO soon?
No public IPO plans have been announced for VesiCURE Therapeutics.
How can I track VesiCURE Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VesiCURE Therapeutics's secondary market activity and sign up for updates.